Literature DB >> 11307589

Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status.

R W Haley1, R P Fischer.   

Abstract

Tattooing in commercial tattoo parlors is known to transmit blood-borne viral infections, including hepatitis C virus (HCV), in other countries, but its contribution to the high population prevalence of HCV infection in the United States has been incompletely evaluated. Risk factors for blood-borne infection were assessed by physician's interview of 626 consecutive patients undergoing medical evaluation for spinal problems in 1991 and 1992 while unaware of their HCV status. Later all were screened for HCV infection with enzyme-linked immunosorbent assay (EIA-1 and EIA-2), and positives were confirmed with second-generation recombinant immunoblot assay (RIBA). Forty-three patients were seropositive for HCV (sample prevalence 6.9%, population-standardized prevalence 2.8%). Logistic regression analysis identified 4 independent risk factors for HCV infection: injection-drug use (adjusted prevalence odds ratio [OR] = 23.0; 95% confidence intervals [CI] = 7.5-70.6), ancillary hospital jobs held by men (OR = 9.6; 95% CI = 3.8-24.3), tattoos from commercial tattoo parlors (OR = 6.5; 95% CI = 2.9-14.8), and drinking > or = 3 6-packs of beer per month (OR = 4.0; 95% CI = 1.8-8.7). If causal, these 4 risk factors account for 91% of HCV infections, with tattooing explaining 41%, heavy beer drinking 23%, injection-drug use 17%, and ancillary health care jobs for men 8%. Transfusions, promiscuous sexual activity, bone grafts, acupuncture, perinatal or intimate transmission in families, and other modes were not independently associated with serologic evidence of HCV infection. Unlikely to be explained by confounding or incomplete disclosure of other risk factors, tattooing in commercial tattoo parlors may have been responsible for more HCV infections than injection-drug use.

Entities:  

Mesh:

Year:  2001        PMID: 11307589     DOI: 10.1097/00005792-200103000-00006

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  18 in total

1.  Hepatitis B virus infection among different sex and age groups in Pakistani Punjab.

Authors:  Fawad Khan; Sulaiman Shams; Ihteshamud Din Qureshi; Muhmmad Israr; Hayat Khan; Muhammad Tahir Sarwar; Muhammad Ilyas
Journal:  Virol J       Date:  2011-05-13       Impact factor: 4.099

Review 2.  Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.

Authors:  Rania A Tohme; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

3.  Prevalence and characteristics of body piercing and tattooing among high school students.

Authors:  Marthe Deschesnes; Stéphanie Demers; Philippe Finès
Journal:  Can J Public Health       Date:  2006 Jul-Aug

4.  The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco.

Authors:  Keith A Hermanstyne; David R Bangsberg; Karen Hennessey; Cindy Weinbaum; Judith A Hahn
Journal:  J Public Health (Oxf)       Date:  2012-03-26       Impact factor: 2.341

5.  [Infections caused by piercing and tattoos--a review].

Authors:  Werner Handrick; Pietro Nenoff; Heidrun Müller; Wolfram Knöfler
Journal:  Wien Med Wochenschr       Date:  2003

Review 6.  Tattooing and risk of hepatitis B: a systematic review and meta-analysis.

Authors:  Siavash Jafari; Jane A Buxton; Kourosh Afshar; Ray Copes; Souzan Baharlou
Journal:  Can J Public Health       Date:  2012 May-Jun

Review 7.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Risk factors for hepatitis C virus infection among patients receiving health care in a Department of Veterans Affairs hospital.

Authors:  Girish Mishra; C Sninsky; Robert Roswell; S Fitzwilliam; Kenneth C Hyams
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

Review 9.  Treatment of hepatitis C virus infection.

Authors:  Kilian Weigand; Wolfgang Stremmel; Jens Encke
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

Review 10.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.